期刊文献+

肝内胆管结石并胆管癌的临床病理和生化特征分析 被引量:1

Analysis of clinical pathological and biochemical features of cholangiocarcinoma associated with hepatolithiasis
下载PDF
导出
摘要 目的探讨肝内胆管结石并胆管癌的临床病理和生化特征。方法选取我院收治的12例肝内胆管癌和同期良性病变(肝内胆管结石14例,肝外胆管结石30例,结石性胆囊炎40例)患者病例资料,通过多因素Logistic回归分析模型探讨乙型肝炎病毒标志物检测,血清非特异性肿瘤标志物(CA19-9、CA125、CEA和AFP)检测,肝内胆管结石等10项影响因素对肝内胆管癌患病率的影响。结果本次研究所纳入病例,肝内胆管癌患者的乙肝病毒携带率或慢性乙肝患病率(33.3%)均明显高于同期的肝外胆管结石和结石性胆囊炎患者(P<0.05);多因素Logistic回归模型显示:肝内胆管结石(OR=1.05,CI为0.92~1.38,P=0.023),乙肝病毒感染(OR=1.02,95%CI为0.78~1.31,P=0.02);ICC患者血清高于参考值的CA19-9和黄疸指数对回归方程亦有贡献(P<0.05)。结论乙型肝炎病毒感染,肝内胆管结石,高于参考值的CA19-9和黄疸指数可能作为提示诊断肝内胆管癌的辅助指标。 Objective To investigate the pathological and biochemical characteristics of intrahepatic bile duct stones and bile duct cancer. Methods Clinical data from the The First Hospital of Shunde including 12 cases of intrahepatic cholangiocarcinoma and the same period of 14 cases of hepatolithiasis, 30 cases of calculus of intrahepatic duct, 40 cases of cholecystitis were collected by cluster sampling;Multivariate Logistic regression model was employed to analyze the correlation between hepatitis B virus markers,non-specific serum tumor markers CA19- 9, CA125, CEA and AFP,calculus of intrahepatic duct and other 10 effect factors on the prevalence of intrahepatic cholangiocarcinoma. Results The prevalence of hepatitis B virus carrier or chronic type B hepatitis in patients with intrahepatic cholangiocarcinoma(33.3%) were significantly higher than that of extrahepatic bile duct stones and cholecystitis patients as the control (P〈0.05); Logistic regression models showed that intrahepatic bile duct stones (OR=1.05,CI,0.92 to 1.38,P=0.023), hepatitis B virus infection (OR=1.02,95% CI 0.78-1.31,P=0.020), high level of serum CA19-9 and jaundice index in patients had slight contribution to the regression equation of ICC (P〈0.05). Conclusion HBV infection, calculus of intrahepatic duct, high level of serum CA19-9 and jaundice index may contribute the diagnosis of intrahepatic cholangiocarcinoma.
出处 《岭南现代临床外科》 2012年第5期280-282,共3页 Lingnan Modern Clinics in Surgery
基金 佛山市卫生局课题(2011483)
关键词 肝内胆管癌 乙型肝炎病毒 肝内胆管结石 CA19—9 病例对照 Cholangiocarcinoma HBV Calculus of intrahepatic duct CA19-9 Case control
  • 相关文献

参考文献6

二级参考文献16

  • 1Xiao-Hui Fu, Zhao-Hui Tang, Ming Zong, Guang-Shun Yang, Xiao-Ping Yao and Meng-Chao Wu Shanghai, China Department of Comprehensive Therapy of Hepatobi- liary Tumors, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):279-283. 被引量:24
  • 2鲁慧英.Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients[J].Chinese Medical Journal,2000(12):82-85. 被引量:6
  • 3苏逢锡,陈积圣,曾韵洁.肝内胆管结石合并肝内胆管癌[J].普外临床,1995,10(6):338-340. 被引量:24
  • 4Kazuhisa U,Hironobu O,Masaji T,et al.Indication and procedure for treatment of hepatolithiasis.Arch Surg,2002,137:149-153.
  • 5Yamamoto M,Takasaki K,Yoshikawa T,et al.Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol,1998,69:162-167.
  • 6Tatsuya T,Takehisa H,Keiichiro K,et al.Lymphatic spreading pattern of intrahepatic cholangiocarcinoma.Surgery,2001,129:401-407.
  • 7Sasaki A,Aramaki M,Kawano K,et al.Intrahepatic peripheral cholangiocarcinoma:mode of spread and choice of surgical treatment.Br J Surg,1998,85:1206-1209.
  • 8Kelley ST,Bloomston M,Serafini F,et al.Cholangiocarcinoma:advocate an aggressive operative approach with adjuvant chemotherapy.Am Surg,2004,70:743-748.
  • 9Jarnagin WR,Shoup M.Surgical management of cholangiocarcinoma.Semin Liver Dis,2004,24:189-199.
  • 10Nanashima A,Yamaguchi H,Shibasaki S,et al.Adjuvant photodynamic therapy for bile duct carcinoma after surgery:a preliminary study.J Gastrol,2004,39:1095-1010.

共引文献52

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部